LFVN — Lifevantage Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 849146 ·
Last close
$6.43
Market Cap
$81.12M
52W High
$11.71
52W Low
$4.53
ADV30
204,283
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 43,716,000 | 34,544,000 | 1,678,000 | 1,362,000 | 62,127,000 | 12,483,000 | 28,788,000 |
| Dec 2025 | 48,931,000 | 36,209,000 | 487,000 | 276,000 | 61,169,000 | 10,181,000 | 28,182,000 |
| Sep 2025 | 47,561,000 | 37,816,000 | 2,268,000 | 2,155,000 | 61,579,000 | 13,091,000 | 28,422,000 |
| Jun 2025 | 55,114,000 | 44,049,000 | 2,148,000 | 1,959,000 | 71,958,000 | 20,201,000 | 37,317,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$3,748,000
Investing CF
$-5,796,000
Financing CF
$-9,405,000
CapEx
$-2,053,000
Dividends Paid
$-2,211,000
Buybacks
$-7,477,000
EPS Diluted TTM
$0.60
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,441,000
Inventory
$18,978,000
Receivables
$4,982,000
ST Investments
—
EBIT TTM
$8,956,000
Pretax Income TTM
$9,290,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$195,323,008
EBITDA
$10,007,000
Free Cash Flow
$2,032,125
Enterprise Value
$78,842,736
Total Cash
$12,483,000
Total Debt
$10,206,000
Shares Out
12,615,822
Trailing EPS
$0.45
Book Value
$2.64
ROE
17.1%
ROA
6.4%
Div Yield
3.11%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 228,530,000 | 12,199,000 | 9,805,000 | 71,958,000 | 37,317,000 | — | 11,878,000 |
| Jun 2024 | 200,164,000 | 4,332,000 | 2,937,000 | 60,299,000 | 34,308,000 | — | 12,197,000 |
| Jun 2023 | 213,398,000 | 4,259,000 | 2,540,000 | 66,123,000 | 31,474,000 | — | 6,828,000 |
| Jun 2022 | 206,360,000 | 7,575,000 | 3,120,000 | 70,706,000 | 39,190,000 | — | 7,959,000 |
TTM Snapshot
Revenues TTM
$203,560,000
NetIncome TTM
$5,546,000
OpCashFlow TTM
$0
Assets (Latest)
$60,299,000
Forward EPS
$0.46
Max Pain — expiry 2026-09-18
max pain strike: $7.50 · spot: $6.43 · call oi: 982 · put oi: 173
Expected Move to 2026-09-18:
±$3.15
(48.99%) —
implied range
$3.28 –
$9.58
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATHE | ALTERITY THERAPEUTICS LTD | $80.12M | $4.42 | — |
| GOSS | Gossamer Bio, Inc. | $83.10M | $0.17 | — |
| TELO | Telomir Pharmaceuticals, Inc. | $83.22M | $1.21 | — |
| RLYB | Rallybio Corp | $84.54M | $15.93 | — |
| BMEA | Biomea Fusion, Inc. | $84.59M | $1.17 | — |
News headlines (Yahoo Finance, 1h cache)
LifeVantage Corporation (NASDAQ:LFVN) Pays A US$0.05 Dividend In Just Three Days
2026-05-28 11:01 · Yahoo
Do Options Traders Know Something About LifeVantage Stock We Don't?
2026-05-27 15:28 · Yahoo
Lake Street Capital Markets Downgrades LifeVantage Corporation (LFVN) After Weak Q3 Results
2026-05-14 05:29 · Yahoo
Lifevantage Q3 Earnings Call Highlights
2026-05-07 02:16 · Yahoo
LifeVantage Corporation Q3 2026 Earnings Call Summary
2026-05-07 00:28 · Yahoo
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
2026-05-06 22:30 · Yahoo
LifeVantage Declares Quarterly Dividend
2026-05-06 20:06 · Yahoo
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
2026-05-06 20:05 · Yahoo
How A Reset Price Target Is Shaping The Evolving Story For LifeVantage (LFVN)
2026-05-03 18:06 · Yahoo
Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?
2026-04-28 10:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.